Brookfield Renewable Partners LP
BEP.UN
Emera Inc
EMA
Bank of Nova Scotia
BNS
4
Choice Properties Real Estate Investment Trust
CHP.UN
5
Enbridge Inc
ENB
CA Stock MarketDetailed Quotes
HLS HLS Therapeutics Inc
- 4.700
- 0.0000.00%
15min DelayMarket Closed Mar 21 16:00 ET
149.43MMarket Cap-5.27P/E (TTM)
4.910High4.700Low21.35KVolume4.850Open4.700Pre Close102.57KTurnover5.48052wk High0.11%Turnover Ratio31.79MShares3.00052wk Low-0.892EPS TTM90.45MFloat Cap24.598Historical HighLossP/E (Static)19.25MShs Float0.043Historical Low-0.892EPS LYR4.47%Amplitude--Dividend TTM1.46P/B1Lot Size--Div YieldTTM
HLS Therapeutics Inc News
HLS Therapeutics Inc.'s (TSE:HLS) Biggest Owners Are Individual Investors Who Got Richer After Stock Soared 18% Last Week
HLS Therapeutics Inc. Receives Buy Rating Amid Strong Financial Performance and Positive 2025 Guidance
HLS Therapeutics Inc (HLS) Receives a Hold From Stifel Nicolaus
HLS Therapeutics Inc: MDA EN
HLS Therapeutics Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
HLS Therapeutics Brief: Launching Normal Course Issuer Bid in March 2025
Press Release: HLS Therapeutics Announces Fiscal 2024 Financial Results and Normal Course Issuer Bid
Press Release: HLS Therapeutics Appoints Christine Elliott to Its Board of Directors
HLS Therapeutics Inc Is Maintained at Hold by Canaccord Genuity
HLS Therapeutics Inc (HLTRF) Q3 2024 Earnings Call Highlights: Strategic Debt Reduction and ...
HLS Therapeutics Q2 Net Loss Narrows With Cut in Expenses, Revenue Falls
Press Release: HLS Therapeutics Announces Q2 2024 Financial Results
Strategic Divestiture and Financial Flexibility: HLS Therapeutics Inc's Optimistic Buy Rating
Stifel Nicolaus Keeps Their Hold Rating on HLS Therapeutics Inc (HLS)
Stocks in Play: HLS Therapeutics Inc.
New Study Published on the Impact of Pharmaceutical Support Programs on Persistence With Clozapine Treatment
HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance
HLS Therapeutics Inc: INTERIM MDA EN
HLS Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
Press Release: HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call
Market Insights
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.
Unlock Now